TREA

79203359 - SANBIO

Follow

Information

  • Trademark
  • 79203359
  • Serial Number
    79203359
  • Registration Number
    5377414
  • Filing Date
    October 26, 2016
    8 years ago
  • Registration Date
    January 16, 2018
    7 years ago
  • Transaction Date
    July 08, 2024
    6 months ago
  • Status Date
    July 08, 2024
    6 months ago
  • Published for Opposition Date
    October 31, 2017
    7 years ago
  • Location Date
    July 08, 2024
    6 months ago
  • Status Code
    739
  • Current Location
    Historical data usage
    Employee Name
    GILLES, DEBORAH LYNN M
  • Attorney Name
    N. Alexander Nolte
  • Owners
Information
Mark Drawing Code
3
Mark Identification
SANBIO
Case File Statements
  • DM0000: The mark consists of the wording "SANBIO" in black with a light green triangle above the "I"; to the left of the wording is a dark green square with two light green bands inside the square and a third light green band partially outside the square. The color white represents background and is not a feature of the mark.
  • GS0051: Pharmaceutical, veterinary preparations and sanitary preparations for gene therapy for medical purposes; pharmaceutical, veterinary preparations and sanitary preparations for cell therapy for medical purposes; pharmaceutical, veterinary preparations and sanitary preparations for regenerative medicine for medical purposes; medicines for treating central nervous system diseases; pharmaceutical, veterinary preparations and sanitary preparations, namely, cells, stem cells and living cells for gene therapy for medical purposes; pharmaceutical, veterinary preparations and sanitary preparations, namely, cells, stem cells and living cells for cell therapy for medical purposes; pharmaceutical, veterinary preparations and sanitary preparations, namely, cells, stem cells and living cells for regenerative medicine for medical purposes
  • PM0001: SAN BIO
  • CC0000: The color(s) black, light green and dark green is/are claimed as a feature of the mark.
  • GS0421: Testing, inspection, research, development and evaluation services for others in the fields of pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals; consulting services in the field of pharmaceutical research and development; and testing, inspection, research, or development of pharmaceutical preparations for gene therapy, cell therapy, regenerative medicine and medicines for treating central nervous system diseases; conducting clinical trials for others in the field of pharmaceutical products, providing medical and scientific research information in the field of pharmaceutical products, and consulting services in the field of pharmaceutical product research and development; conducting clinical trials for others, providing medical and scientific research information in the field of clinical trials, and consulting services for others in the field of design, planning, and implementation project management of clinical trials; medical research, compiling data for research purposes in the field of medical consultancy, and providing medical research information in the field of pharmaceuticals, gene therapy, cell therapy for medical purposes, regenerative medicine and medicines for treating central nervous system diseases; scientific research and development, scientific research, analysis, and testing in the field of pharmaceutical product development, gene therapy development, cell therapy for medical purposes development, regenerative medicine development and central nervous system diseases therapy development, consulting services in the field of pharmaceutical product research and development, gene therapy research and development, cell therapy for medical purposes research and development, regenerative medicine research and development and central nervous system diseases therapy medicine research and development, and providing scientific research information in the field of pharmaceuticals, gene therapy, cell therapy regenerative medicine and central nervous system diseases therapy medicine
Case File Event Statements
  • 3/21/2017 - 7 years ago
    4 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 3/16/2017 - 7 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 3/17/2017 - 7 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 3/17/2017 - 7 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/25/2017 - 7 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/26/2017 - 7 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 3/28/2017 - 7 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 3/28/2017 - 7 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 4/15/2017 - 7 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 8/14/2017 - 7 years ago
    10 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 8/14/2017 - 7 years ago
    11 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 8/15/2017 - 7 years ago
    12 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 8/16/2017 - 7 years ago
    13 - TEAS VOLUNTARY AMENDMENT RECEIVED Type: PARI
  • 8/31/2017 - 7 years ago
    14 - ASSIGNED TO LIE Type: ALIE
  • 9/2/2017 - 7 years ago
    15 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 9/2/2017 - 7 years ago
    16 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 9/25/2017 - 7 years ago
    17 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 9/25/2017 - 7 years ago
    18 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 9/25/2017 - 7 years ago
    19 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 9/25/2017 - 7 years ago
    20 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 9/25/2017 - 7 years ago
    21 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 9/26/2017 - 7 years ago
    22 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 10/11/2017 - 7 years ago
    23 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 10/11/2017 - 7 years ago
    24 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 10/11/2017 - 7 years ago
    25 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 10/29/2017 - 7 years ago
    26 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 10/31/2017 - 7 years ago
    27 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 10/31/2017 - 7 years ago
    28 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 1/16/2018 - 7 years ago
    29 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 4/16/2018 - 6 years ago
    30 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 4/20/2018 - 6 years ago
    31 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 4/20/2018 - 6 years ago
    32 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 6/15/2018 - 6 years ago
    33 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 1/16/2023 - 2 years ago
    34 - COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED Type: REM3
  • 10/24/2023 - a year ago
    35 - TEAS SECTION 71 & 15 RECEIVED Type: ES75
  • 7/2/2024 - 6 months ago
    36 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 7/8/2024 - 6 months ago
    37 - REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. Type: C75A
  • 7/8/2024 - 6 months ago
    38 - NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED Type: NA75